Key statistics
On Friday, argenx SE (ARGXN:MEX) closed at 11,075.64, -9.80% below its 52-week high of 12,279.20, set on Dec 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11,075.64 |
---|---|
High | 11,075.64 |
Low | 11,075.64 |
Bid | -- |
Offer | -- |
Previous close | 11,075.64 |
Average volume | -- |
---|---|
Shares outstanding | 61.20m |
Free float | 60.88m |
P/E (TTM) | 34.84 |
Market cap | 34.41bn USD |
EPS (TTM) | 16.08 USD |
Data delayed at least 20 minutes, as of Jun 13 2025 12:30 BST.
More ▼
Announcements
- argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
- argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
- argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
- argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
- argenx Announces Results of Annual General Meeting of Shareholders
- argenx Reports First Quarter 2025 Financial Results and Provides Business Update
- argenx to Present at BofA Securities 2025 Health Care Conference
- argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
- argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- argenx Announces Annual General Meeting of Shareholders on May 27, 2025
More ▼